HIV-Tb Confections Among HIV Patients
Prevalence of HIV-Tb co Infections Among HIV Patients and Their CD4+ T Cell Status-A Single Centre Study in India
1 other identifier
observational
219
1 country
1
Brief Summary
A cross sectional study would be done for prevalence of HIV-Tb. co infection among patients of HIV enrolled at ART centre, Khagaria, India, during June' 2015 to May' 2016. A comparative study of CD4 (cluster of differentiation 4) T cell count among HIV-Tb. co infected patient and HIV patients would be taken in account.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 5, 2016
CompletedFirst Posted
Study publicly available on registry
November 16, 2016
CompletedResults Posted
Study results publicly available
August 7, 2017
CompletedOctober 4, 2017
September 1, 2017
11 months
November 5, 2016
January 23, 2017
September 6, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of HIV/Tb. co Infections Among Patients of HIV Enrolled at ART Center.
% Prevalence of HIV/Tb. co infections= no.of HIV/Tb. co infection (48)/total no. of enrolled patients of HIV including HIV/Tb. co infections (219) x 100, i.e. 21.9%
12 months
Secondary Outcomes (1)
Comparing CD4+ T Cell Count in HIV-Tb. and HIV Cases.
12 months
Study Arms (2)
HIV mono infection
HIV Patients do not have active Mycobacterium Tuberculosis infection
HIV-Tb. co infection
Patients with HIV and MycobacteriumTuberculosis co infections
Eligibility Criteria
HIV population
You may qualify if:
- Patients of HIV+ enrolled ART centre
You may not qualify if:
- Lost to follow up patients (LFU)
- Patients died before the treatment started
- Children below 5 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ART centre, Sadar Hospital
Khagaria, Bihar, 851204, India
Related Publications (4)
Festenstein F, Grange JM. Tuberculosis and the acquired immune deficiency syndrome. J Appl Bacteriol. 1991 Jul;71(1):19-30. No abstract available.
PMID: 1894579BACKGROUNDGetahun H, Gunneberg C, Granich R, Nunn P. HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010 May 15;50 Suppl 3:S201-7. doi: 10.1086/651492.
PMID: 20397949BACKGROUNDGlobal Tuberculosis Report 2016, World Health Organisation, Geneva.
BACKGROUNDPerrin F, Breen R, Lipman M. : HIV and Tuberculosis co-infection. ABC of HIV and AIDS. Michael W, et al (ed): Wiley-Blackwell, BMJ Publishing Group Limited 6:42-47,2012
BACKGROUND
Limitations and Caveats
this is a cross sectional study; findings are limited to the patients attending ART centre.
Results Point of Contact
- Title
- Dr. Ranjan K Singh
- Organization
- SinghRK
Study Officials
- PRINCIPAL INVESTIGATOR
Ranjan K Singh, M.D.
Physician cum nodal officer, ART centre, Khagaria, India.
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDIV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Nodal officer of ART centre, Sadar Hospital.
Study Record Dates
First Submitted
November 5, 2016
First Posted
November 16, 2016
Study Start
June 1, 2015
Primary Completion
May 1, 2016
Study Completion
November 1, 2016
Last Updated
October 4, 2017
Results First Posted
August 7, 2017
Record last verified: 2017-09
Data Sharing
- IPD Sharing
- Will share